Headlines & Research Highlights
A new paper published by TRIUMF Theory Department scientist Jason Holt and colleagues from the University of Washington and Germany has provided first-principles predictions of which isotopes can and can’t exist for elements from helium to iron.
Health Canada has approved cyclotron-produced technetium-99m, greenlighting the made-in-Canada technology for national implementation and opening the door to a greener, more reliable way to make the most commonly used medical isotope.
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment.
TRIUMF is pleased to welcome Ms. Shari Wallace as its new Chief Information Officer (CIO)